Antiviral Therapy Associated with Fewer Recurring Eye Problems from Herpes Simplex Virus

Author: JAMA and Archives Journals
Published: 2010/09/13 - Updated: 2010/09/25
Topic: Herpes Simplex Virus - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations.

Introduction

Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Main Item

Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

"Herpes simplex virus (HSV) is a common cause of corneal disease and is the leading infectious cause of corneal blindness among developed nations," the authors write as background information in the article. After the initial exposure to the virus and the resulting systemic infection, herpes simplex establishes a latent infection in sensory nerve structures. Reactivation of this latent infection could lead to initial or recurrent disease in one or both eyes, including inflammation or infection of the cornea, eyelid, membrane inside the eye (conjunctivitis, or pink eye) or middle layer of the eye (uveitis).

Ryan C. Young, B.A., of Mayo Clinic, Rochester, Minn., and colleagues estimated the incidence of HSV eye disease in a community-based cohort, in Olmstead County, Minnesota, from 1976 through 2007. During this time period, 394 patients with ocular HSV were identified, for an annual incidence of 11.8 per 100,000 individuals.

Oral antiviral therapy was prescribed in 175 (44 percent) of these patients, who underwent therapy for an average of 2.8 years (36 percent of the average 7.7 years of follow-up). Patients not taking this prophylactic therapy were 9.4 times more likely to have a recurrence of epithelial keratitis (infection of the top layer of the cornea), 8.4 times more likely to have a recurrence of stromal keratitis (infection of deeper layers of the cornea) and 34.5 times more likely to have a recurrence of blepharitis (eyelid infection) or conjunctivitis than those taking antiviral medications.

A total of 20 patients experienced adverse outcomes, including visual loss and perforation of the cornea; of these, 17 (85 percent) were not taking oral antiviral prophylaxis.

"Overall, this community-based retrospective study demonstrated a stable incidence of HSV eye disease during a recent 32-year period," the authors write. "We found a more dramatic protective effect of oral antiviral prophylaxis on recurrences of ocular HSV than had been described previously."

"The results of this study suggest that oral antiviral prophylaxis should be considered for patients with frequent recurrences of corneal disease," they conclude. "Additionally, we recommend an evaluation of the possible barriers preventing compliance with antiviral prophylaxis and a reassessment of the cost-effectiveness of long-term oral antiviral therapy."

(Arch Ophthalmol. 2010;128[9]:1178-1183. Available pre-embargo to the media at www.jamamedia.org.)

This study was supported by an unrestricted grant from Research to Prevent Blindness Inc. and the Mayo Foundation.

Explore Similar Topics

- An international team of scientists uncovered and sequenced ancient genomes from the herpes virus that commonly causes lip sores.

- WHO global estimate reveals over 3.7 billion people under the age of 50 are currently infected with herpes simplex virus type 1 (HSV-1).

Citing and References

Founded in 2004, Disabled World (DW) is a leading resource on disabilities, assistive technologies, and accessibility, supporting the disability community. Learn more on our About Us page.

Cite This Page: JAMA and Archives Journals. (2010, September 13 - Last revised: 2010, September 25). Antiviral Therapy Associated with Fewer Recurring Eye Problems from Herpes Simplex Virus. Disabled World (DW). Retrieved April 20, 2025 from www.disabled-world.com/health/dermatology/herpes/eyes-herpes.php

Permalink: <a href="https://www.disabled-world.com/health/dermatology/herpes/eyes-herpes.php">Antiviral Therapy Associated with Fewer Recurring Eye Problems from Herpes Simplex Virus</a>: Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.